Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Eastern Nephrology Associates

Neither a doctor nor a teaching hospital

Research payments

$1,236,900

2,145 payments

Through program year 2025, Eastern Nephrology Associates is reported as receiving $1,236,900 in research payments, across 2,145 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $150,034 9
2024 Research $132,172 143
2023 Research $272,121 415
2022 Research $129,622 447
2021 Research $190,420 719
2020 Research $151,787 231
2019 Research $210,742 181

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $789,958 1,992 payments
  2. AstraZeneca Pharmaceuticals LP $181,207 13 payments
  3. Bayer HealthCare Pharmaceuticals Inc. $114,509 107 payments
  4. AstraZeneca UK Limited $73,573 3 payments
  5. Apellis Pharmaceuticals, Inc. $31,779 13 payments
  6. Gilead Sciences, Inc. $25,500 3 payments
  7. Akebia Therapeutics Inc $13,737 4 payments
  8. CSL Behring $4,959 7 payments
  9. Sanofi US Services Inc. $1,677 3 payments
Studies the money was for Research payments · program years 2019–2025
  1. Ex9924-4473 $465,627 1,246 payments
  2. Nn9535-4321 $95,414 386 payments
  3. A Randomized, Double Blind, Placebo Controlled, Multicenter, Parallel Group, Dose Ranging Study to Evaluate CIN 107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease $92,989 7 payments
  4. Cardiovascular Renal and Metabolism Lokelma Hyperkalemia $85,815 2 payments
  5. Nn9924-4635 $80,806 94 payments
  6. Nn9838-4862 $71,609 205 payments
  7. BAY94-8862 ph 3 conventional in diabetic nephropathy $68,745 62 payments
  8. Phase 2b Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants with APOL1-Mediated Kidney Disease (APPRECIATE) $65,073 2 payments
  9. Nn1250-4252 $63,773 6 payments
  10. BAY 94-8862 ph 3 conventional in diab nephropathy $45,764 45 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record